These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27044480)

  • 1. Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches.
    Friesen KJ; Woelk C; Bugden S
    CMAJ; 2016 Jun; 188(9):648-653. PubMed ID: 27044480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, safety and pharmacokinetic study of a novel fentanyl-containing matrix transdermal patch system in Japanese patients with cancer pain.
    Miyazaki T; Hanaoka K; Namiki A; Ogawa S; Kitajima T; Hosokawa T; Ishida T; Nogami S; Mashimo S
    Clin Drug Investig; 2008; 28(5):313-25. PubMed ID: 18407717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
    Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
    J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids.
    Mystakidou K; Befon S; Tsilika E; Dardoufas K; Georgaki S; Vlahos L
    Oncology; 2002; 62(1):9-16. PubMed ID: 11810038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fentanyl tolerance in the treatment of cancer pain: a case of successful opioid switching from fentanyl to oxycodone at a reduced equivalent dose.
    Sutou I; Nakatani T; Hashimoto T; Saito Y
    J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):161-5. PubMed ID: 26095488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of opioid patch initiation in Australian residential aged care.
    Gadzhanova S; Roughead EE; Pont LG
    Med J Aust; 2015 Oct; 203(7):298. PubMed ID: 26424066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.
    Grond S; Radbruch L; Lehmann KA
    Clin Pharmacokinet; 2000 Jan; 38(1):59-89. PubMed ID: 10668859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy.
    Ripamonti C; Fagnoni E; Campa T; Brunelli C; De Conno F
    Support Care Cancer; 2006 May; 14(5):400-7. PubMed ID: 16485087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based study of transdermal fentanyl initiation in Australian clinical practice.
    Gisev N; Pearson SA; Larance B; Larney S; Blanch B; Degenhardt L
    Eur J Clin Pharmacol; 2019 Mar; 75(3):401-408. PubMed ID: 30392109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain.
    Payne R
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):47-53. PubMed ID: 9671331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of transdermal fentanyl patches for opioid initiation in patients with gastrointestinal obstruction].
    Miyoshi T; Yamauchi H; Misumi N; Goto T; Kai S; Yoshida E; Nishino T; Hasuo Y
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1401-5. PubMed ID: 25434443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indication of Adequate Transdermal Fentanyl Dose in Opioid Switching From Oral Oxycodone in Patients With Cancer.
    Matsumura C; Yamada M; Fujihara S; Chisaki Y; Takahashi K; Yano Y
    Am J Hosp Palliat Care; 2016 Mar; 33(2):109-14. PubMed ID: 25324418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
    Mitra F; Chowdhury S; Shelley M; Williams G
    Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.
    Kornick CA; Santiago-Palma J; Moryl N; Payne R; Obbens EA
    Drug Saf; 2003; 26(13):951-73. PubMed ID: 14583070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
    Tawfik MO; Bryuzgin V; Kourteva G;
    Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of fentanyl in sweat and hair of a patient using transdermal patches.
    Schneider S; Ait-M-Bark Z; Schummer C; Lemmer P; Yegles M; Appenzeller B; Wennig R
    J Anal Toxicol; 2008 Apr; 32(3):260-4. PubMed ID: 18397579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily application of transdermal fentanyl patches in patients receiving hyperbaric oxygen therapy.
    Pawasauskas J; Perdrizet G
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):226-32. PubMed ID: 25102042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.